Introduction
Osteoarthritis (OA) is a degenerative and progressive joint disease that affects approximately 500 million people globally.1 Common risk factors for OA include advanced age, female gender, obesity, prior joint injuries, and chronic joint overuse, all of which contribute to disrupted load distribution.2,3 Inflammation plays a distinct role in the development and progression of OA across these phenotypes. Specific genetic alterations in proteins involved in inflammatory processes or cartilage matrix components may increase susceptibility to OA.4 While OA is a widespread condition, current treatment options are primarily aimed at alleviating its symptoms—pain and mobility issues.5 Pain management and physical therapy are the cornerstone approaches for primary treatment, as current interventions cannot…